MedPath

Effect of Caraway Powder consumption on the Treatment of Type 2 Diabetes

Phase 3
Conditions
type 2 diabetes.
Type 2 diabetes mellitus without complications
Registration Number
IRCT20181207041876N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
48
Inclusion Criteria

given diabetes and having a fasting blood suger level of 126 to 250 mg / dL
Consumption of oral glucose-lowering medicines
Age range of 30 to 65 years
Body mass index 25 to 40

Exclusion Criteria

given Chronic diseases (high blood pressure, heart, kidney, hypothyroidism, liver, systemic infection)
Pregnancy and lactation
Hypersensitivity to Caraway

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath